Literature DB >> 23542380

Phenotypic properties of transmitted founder HIV-1.

Nicholas F Parrish1, Feng Gao, Hui Li, Elena E Giorgi, Hannah J Barbian, Erica H Parrish, Lara Zajic, Shilpa S Iyer, Julie M Decker, Amit Kumar, Bhavna Hora, Anna Berg, Fangping Cai, Jennifer Hopper, Thomas N Denny, Haitao Ding, Christina Ochsenbauer, John C Kappes, Rachel P Galimidi, Anthony P West, Pamela J Bjorkman, Craig B Wilen, Robert W Doms, Meagan O'Brien, Nina Bhardwaj, Persephone Borrow, Barton F Haynes, Mark Muldoon, James P Theiler, Bette Korber, George M Shaw, Beatrice H Hahn.   

Abstract

Defining the virus-host interactions responsible for HIV-1 transmission, including the phenotypic requirements of viruses capable of establishing de novo infections, could be important for AIDS vaccine development. Previous analyses have failed to identify phenotypic properties other than chemokine receptor 5 (CCR5) and CD4+ T-cell tropism that are preferentially associated with viral transmission. However, most of these studies were limited to examining envelope (Env) function in the context of pseudoviruses. Here, we generated infectious molecular clones of transmitted founder (TF; n = 27) and chronic control (CC; n = 14) viruses of subtypes B (n = 18) and C (n = 23) and compared their phenotypic properties in assays specifically designed to probe the earliest stages of HIV-1 infection. We found that TF virions were 1.7-fold more infectious (P = 0.049) and contained 1.9-fold more Env per particle (P = 0.048) compared with CC viruses. TF viruses were also captured by monocyte-derived dendritic cells 1.7-fold more efficiently (P = 0.035) and more readily transferred to CD4+ T cells (P = 0.025). In primary CD4+ T cells, TF and CC viruses replicated with comparable kinetics; however, when propagated in the presence of IFN-α, TF viruses replicated to higher titers than CC viruses. This difference was significant for subtype B (P = 0.000013) but not subtype C (P = 0.53) viruses, possibly reflecting demographic differences of the respective patient cohorts. Together, these data indicate that TF viruses are enriched for higher Env content, enhanced cell-free infectivity, improved dendritic cell interaction, and relative IFN-α resistance. These viral properties, which likely act in concert, should be considered in the development and testing of AIDS vaccines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542380      PMCID: PMC3637789          DOI: 10.1073/pnas.1304288110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  82 in total

1.  Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications.

Authors:  J Ongradi; L Ceccherini-Nelli; M Pistello; S Specter; M Bendinelli
Journal:  AIDS Res Hum Retroviruses       Date:  1990-12       Impact factor: 2.205

2.  Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.

Authors:  Bhavna Chohan; Dorothy Lang; Manish Sagar; Bette Korber; Ludo Lavreys; Barbra Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

4.  High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

Authors:  Hui Li; Katharine J Bar; Shuyi Wang; Julie M Decker; Yalu Chen; Chuanxi Sun; Jesus F Salazar-Gonzalez; Maria G Salazar; Gerald H Learn; Charity J Morgan; Joseph E Schumacher; Peter Hraber; Elena E Giorgi; Tanmoy Bhattacharya; Bette T Korber; Alan S Perelson; Joseph J Eron; Myron S Cohen; Charles B Hicks; Barton F Haynes; Martin Markowitz; Brandon F Keele; Beatrice H Hahn; George M Shaw
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

5.  A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24.

Authors:  Angélique Biancotto; Beda Brichacek; Silvia S Chen; Wendy Fitzgerald; Andrea Lisco; Christophe Vanpouille; Leonid Margolis; Jean-Charles Grivel
Journal:  J Virol Methods       Date:  2009-01-06       Impact factor: 2.014

6.  Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma.

Authors:  Julie A Martellini; Amy L Cole; Nitya Venkataraman; Gerry A Quinn; Pavel Svoboda; Bhushan K Gangrade; Jan Pohl; Ole E Sørensen; Alexander M Cole
Journal:  FASEB J       Date:  2009-06-01       Impact factor: 5.191

7.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

8.  Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

Authors:  Florian Hladik; Polachai Sakchalathorn; Lamar Ballweber; Gretchen Lentz; Michael Fialkow; David Eschenbach; M Juliana McElrath
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

9.  Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors.

Authors:  A Granelli-Piperno; B Moser; M Pope; D Chen; Y Wei; F Isdell; U O'Doherty; W Paxton; R Koup; S Mojsov; N Bhardwaj; I Clark-Lewis; M Baggiolini; R M Steinman
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  The interferon response inhibits HIV particle production by induction of TRIM22.

Authors:  Stephen D Barr; James R Smiley; Frederic D Bushman
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more
  233 in total

1.  ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.

Authors:  Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

2.  Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.

Authors:  Vanessa L Naidoo; Jaclyn K Mann; Christie Noble; Emily Adland; Jonathan M Carlson; Jake Thomas; Chanson J Brumme; Christina F Thobakgale-Tshabalala; Zabrina L Brumme; Mark A Brockman; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.

Authors:  Philippe Selhorst; Carina Combrinck; Nonkululeko Ndabambi; Sherazaan D Ismail; Melissa-Rose Abrahams; Miguel Lacerda; Natasha Samsunder; Nigel Garrett; Quarraisha Abdool Karim; Salim S Abdool Karim; Carolyn Williamson
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Follicular Regulatory T Cells Are Highly Permissive to R5-Tropic HIV-1.

Authors:  Shannon M Miller; Brodie Miles; Kejun Guo; Joy Folkvord; Amie L Meditz; Martin D McCarter; David N Levy; Samantha MaWhinney; Mario L Santiago; Elizabeth Connick
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

5.  Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.

Authors:  Marilia Rita Pinzone; Erin Graf; Lindsay Lynch; Brigit McLaughlin; Frederick M Hecht; Mark Connors; Stephen A Migueles; Wei-Ting Hwang; Giuseppe Nunnari; Una O'Doherty
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

6.  Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants.

Authors:  Philippe Selhorst; Lindi Masson; Sherazaan D Ismail; Natasha Samsunder; Nigel Garrett; Leila E Mansoor; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore; Carolyn Williamson
Journal:  Clin Infect Dis       Date:  2016-09-29       Impact factor: 9.079

7.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Authors:  Merlin L Robb; Leigh A Eller; Hannah Kibuuka; Kathleen Rono; Lucas Maganga; Sorachai Nitayaphan; Eugene Kroon; Fred K Sawe; Samuel Sinei; Somchai Sriplienchan; Linda L Jagodzinski; Jennifer Malia; Mark Manak; Mark S de Souza; Sodsai Tovanabutra; Eric Sanders-Buell; Morgane Rolland; Julie Dorsey-Spitz; Michael A Eller; Mark Milazzo; Qun Li; Andrew Lewandowski; Hao Wu; Edith Swann; Robert J O'Connell; Sheila Peel; Peter Dawson; Jerome H Kim; Nelson L Michael
Journal:  N Engl J Med       Date:  2016-05-18       Impact factor: 91.245

9.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

10.  Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING.

Authors:  Maud Trotard; Nikolaos Tsopoulidis; Nadine Tibroni; Joschka Willemsen; Marco Binder; Alessia Ruggieri; Oliver T Fackler
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.